Saturday, August 22, 2020 10:25:30 PM
10,000 locations that will soon have Elite’s Adderalls due to
best cost basis In industry.
Proves once dominant Teva is being replaced by Elite. Also Elite has a better price then Teva.
Simple Teva was the only manufacturer at this pharmacy for generic Adderall for the last 7 to 10 years( that I am aware of), now elite shows up with regular supply every week and corporate purchasing shows Elite as preferred manufacturer and the result slowly but surely lot more Elite on the shelves.
Update to my previous post with proofs!! Here are 4 screen shots showing inventory and movement of generic adderall 20 mg both Teva and Lanett in 2 different districts ( Carolina South and Colorado North). I just chose 2 random districts. When I said physically counting the number of tablets I meant not me but its required by law and these numbers listed are acurate down to the last tablet. Also if you see the last row you will see the number of days that particular quantity lasts at that pharmacy so as an example if a store has 1000 tablets and days supply is 8, it usually means they go through 1000 tablets in 8 days!!
Just looking at these 2 districts alone they have close to 25,000 lanett adderall 20 mg. Now multiply that with almost 110 districts and all the other strengths of lanett adderall's and you are looking at quite a large inventory out there. Also you can see that Carolina district have not fully embraced lanett adderall compared to colorado(looking at days supply gives you that!!).
As I said I am not here to pump the stock in anyway, giving you the research I did. I am just waiting for the lanett adderall xr's to drop and I will surely buy a lot of ELTP!! The xr's are considerably higher priced ( averaging about $120 dollars a bottle for the current prefered generic adderall xr).
You guys have no idea how popular the generic adderalls are with a chain like Walgreens( I can talk about it as I know the info!! Now don't question my source). I checked Elite's penetration of generic Adderall 20 ( FYI 20 mg is the most sold)in US markets (Walgreens stores), except for west coast states most states have or in the process of switch over to Lanett Adderall from Teva. I Physically counted inventory upwards of 40000 to 500000 ( number of tablet sales in a given 2 week period) in just 4 big markets!! I am not saying to pump the stock up as it's the truth! Teva cannot meet the demand this medication has and cannot keep the wholesalers shelves stocked so Lanett comes in and that at a price point better than Teva.
Just to clarify there is a shortage of the 20 mg ir since about March, I am a pharmacist and a pharmacy manager. There are other brands available but the Barr brand costs about 12 bucks a bottle and the rest of them start at 3 times the price of Barr and no pharmacy wants to stock them of course! At last check there were 15 bottles of Barr available at my wholesaler vs other 110 bottles of other brands which are not popular at all. This particular wholesaler supplies to roughly 400 pharmacies comprising 8 counties just an FYI. At my pharmacy we go through 5 to 6 bottles a week of this 20 mg.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/23/2025 11:05:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 11:05:36 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
